Loading clinical trials...
Loading clinical trials...
Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Care
Conditions
Interventions
Urine sample
Phone call at day 28
Locations
1
France
Hôpital Privé de l'Ouest Parisien
Trappes, France
Start Date
March 17, 2025
Primary Completion Date
November 5, 2025
Completion Date
December 5, 2025
Last Updated
October 2, 2025
NCT07546435
NCT06427941
NCT05732779
NCT03067181
NCT06019182
NCT06689085
Lead Sponsor
Ramsay Générale de Santé
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions